NS
Natarajan Sethuraman
DELAYED 1 MONTH
President, Research & Develop.
Entrada Therapeutics, Inc.
Filings
2
Companies
1
Latest
May 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
68
TRDACLUSTER 2
Entrada Therapeutics, Inc.
Natarajan Sethuraman
President, Research & Develop.
Sale
$398.8K
25,907 sh
May 4 11:25 PM
May 4, 2026